The risk of patient cross-contamination from Venturi-Principle atomizers

Area of Science:

• Otolaryngology
• Infection Control
• Medical Device Safety

Background:

• Otolaryngology clinicians treat patients with diverse transmissible infections, including MRSA, TB, and HIV.
• Topical anesthetics and decongestants are commonly administered using air-driven atomizers.
• The DeVilbiss atomizer, operating on the Venturi principle, has a known potential for cross-contamination.

Purpose of the Study:

• To review the mechanism of action of the air-driven DeVilbiss atomizer.
• To discuss existing literature demonstrating the risk of patient cross-contamination associated with this device.

Main Methods:

• Literature review of studies on air-driven atomizers and cross-contamination.
• Analysis of the Venturi principle's role in atomizer function.
• Examination of infection transmission pathways in otolaryngology settings.

Main Results:

• The DeVilbiss atomizer's design facilitates the potential for aerosolization and transmission of pathogens.
• Evidence suggests a risk of cross-contamination between patients via the atomizer.
• Understanding the mechanism is crucial for mitigating infection risks.

Conclusions:

• The air-driven DeVilbiss atomizer poses a potential cross-contamination risk in otolaryngology.
• Clinicians should be aware of this risk and implement appropriate infection control measures.
• Further research may be needed to quantify the risk and develop safer alternatives.